WHO ICTRP trial
A Study of YM178 in Subjects With Symptoms of Overactive Bladder
CTRI/2010/091/000535 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2010/091/000535 |
|---|---|
| Public title | A Study of YM178 in Subjects With Symptoms of Overactive Bladder |
| Scientific title | Phase III study of YM178 - A randomized, double-blind, parallel group, placebo and active controlled, multi-center study in subjects with symptoms of overactive bladder |
| Primary sponsor | Astellas Pharma Inc |
| Secondary sponsors | Quintiles Research India Private Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India;China;Republic of Korea;Taiwan |
| Conditions | Health Condition 1: N329- Bladder disorder, unspecified Health Condition 2: null- Symptoms of overactive bladder |
| Interventions | Intervention1: YM178 modified-release tablet: Oral, Dose X Once Daily Control Intervention1: Tolterodine Capsule: Oral, Dose Y Once Daily Control Intervention2: Placebo Tablet/Capsule: Oral, Dose X/Y Once Daily |
| Registration date | May 21, 2010 |
| Target size | 1300 |
| Secondary IDs | 178-CL-090, Ver 2.0 dtd 28-01-10, Addendum 3 dtd 22-02-11;NCT01043666 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: